Humab strives to improve health and well-being
for the humankind through genome engineering.

- Humab develops SynThese™, a transgenic antibody platform,
by utilizing our genome engineering technology.
- SynThese™ is a powerful tool that can produce human monoclonal antibodies.
- Humab will lead development of new antibody drugs via collaboration or
co-development with global pharmaceutical companies.

Genome Engineering

Mouse AntibodyMouse lgH locusMouse lgL locusFully Human AntibodyHuman lgH locusHuman lgL locus

Genome Engineering


Human Antibody from Synthese